Skip to main content

Advertisement

Log in

Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dalmau JO, Posner JB (1997) Paraneoplastic syndromes affecting the nervous system. Semin Oncol 24:318–328

    CAS  PubMed  Google Scholar 

  2. Asproudis IC, Nikas AN, Psilas KG (2005) Paraneoplastic optic neuropathy in a patient with a non-small cell lung carcinoma: a case report. Eur J Ophthalmol 15:420–423

    CAS  PubMed  Google Scholar 

  3. Bernal F, Shamsili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, Honnorat J, Sillevis Smitt P, Graus F (2003) Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 60:230–34

    CAS  PubMed  Google Scholar 

  4. Cross SA, Salomao DR, Parisi JE, Kryzer TJ, Bradley EA, Mines JA, Lam BL, Lennon VA (2003) Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 54:38–0

    Article  PubMed  Google Scholar 

  5. Hoh ST, Teh M, Chew SJ (1991) Paraneoplastic optic neuropathy in nasopharyngeal carcinoma-report of a case. Singapore Med J 32:170–73

    CAS  PubMed  Google Scholar 

  6. Ing EB, Augsburger JJ, Eagle RC (1996) Lung cancer with visual loss. Surv Ophthalmol 40:505–10

    Article  CAS  PubMed  Google Scholar 

  7. Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, Posner JB, Dalmau J (1997) Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 120:1279–300

    Article  PubMed  Google Scholar 

  8. Peterson K, Rosenblum MK, Kotanides H, Posner JB (1992) Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42:1931–937

    CAS  PubMed  Google Scholar 

  9. Honnorat J, Antoine JC, Derrington E, Aguera M, Belin MF (1996) Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 61:270–78

    Article  CAS  PubMed  Google Scholar 

  10. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA (2001) CRMP-5 neuronal autoantibody: marker of lung cancer and thymomarelated autoimmunity. Ann Neurol 49:146–54

    Article  CAS  PubMed  Google Scholar 

  11. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler Ch, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–140

    Article  CAS  PubMed  Google Scholar 

  12. Bataller L, Dalmau JO (2004) Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. Semin Neurol 24:461–71

    Article  PubMed  Google Scholar 

  13. de la Sayette V, Bertran F, Honnorat J, Schaeffer S, Iglesias S, Defer G (1998) Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumour. Arch Neurol 55:405–08

    Article  CAS  PubMed  Google Scholar 

  14. Lladó A, Mannucci P, Carpentier AF, Paris S, Blanco Y, Saiz A, Delattre JY, Graus F (2004) Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes. Neurology 63:1947–949

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adrián Arés-Luque.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arés-Luque, A., García-Tuñón, L.A., Saiz, A. et al. Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies. J Neurol 254, 1131–1132 (2007). https://doi.org/10.1007/s00415-006-0471-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0471-x

Keywords

Navigation